A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
EA to the Vice-Provost (Enterprise)
T: 020 7679 7538
Julia is Executive Assistant to the Vice-Provost (Enterprise) and is responsible for managing his diary and day-to-day correspondence, as well as coordinating corporate reporting from the Office of the Vice-Provost (Enterprise) and being departmental administrator for the office of the Vice-Provost (Enterprise). She is also secretary to the Enterprise Steering Committee.
Before joining UCL Enterprise, Julia worked for the General Teaching Council for England, and previously City University.